Group One Trading’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $24.2K | Sell |
2,991
-202
| -6% | -$1.63K | ﹤0.01% | 1411 |
|
2025
Q1 | $26.8K | Buy |
3,193
+2,494
| +357% | +$20.9K | ﹤0.01% | 1269 |
|
2024
Q4 | $5.54K | Buy |
+699
| New | +$5.54K | ﹤0.01% | 1633 |
|
2024
Q3 | – | Hold |
0
| – | – | – | 1749 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 1778 |
|
2024
Q1 | – | Hold |
0
| – | – | – | 1797 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 1912 |
|
2023
Q3 | – | Sell |
-880
| Closed | -$2.73K | – | 1954 |
|
2023
Q2 | $2.73K | Buy |
+880
| New | +$2.73K | ﹤0.01% | 1483 |
|
2023
Q1 | – | Sell |
-35,532
| Closed | -$70.7K | – | 1865 |
|
2022
Q4 | $70.7K | Sell |
35,532
-385,477
| -92% | -$767K | ﹤0.01% | 1005 |
|
2022
Q3 | $850K | Sell |
421,009
-71,279
| -14% | -$144K | ﹤0.01% | 442 |
|
2022
Q2 | $1.57M | Buy |
492,288
+372,128
| +310% | +$1.18M | ﹤0.01% | 334 |
|
2022
Q1 | $501K | Buy |
120,160
+6,306
| +6% | +$26.3K | ﹤0.01% | 748 |
|
2021
Q4 | $545K | Buy |
113,854
+78,102
| +218% | +$374K | ﹤0.01% | 860 |
|
2021
Q3 | $191K | Buy |
35,752
+11,713
| +49% | +$62.6K | ﹤0.01% | 1139 |
|
2021
Q2 | $123K | Sell |
24,039
-1,095
| -4% | -$5.6K | ﹤0.01% | 1265 |
|
2021
Q1 | $169K | Buy |
+25,134
| New | +$169K | ﹤0.01% | 1078 |
|
2020
Q4 | – | Sell |
-3,836
| Closed | -$15K | – | 1660 |
|
2020
Q3 | $15K | Buy |
+3,836
| New | +$15K | ﹤0.01% | 1261 |
|
2020
Q2 | – | Sell |
-41,133
| Closed | -$143K | – | 1400 |
|
2020
Q1 | $143K | Sell |
41,133
-18,855
| -31% | -$65.6K | ﹤0.01% | 610 |
|
2019
Q4 | $289K | Buy |
59,988
+21,237
| +55% | +$102K | ﹤0.01% | 549 |
|
2019
Q3 | $112K | Buy |
38,751
+37,300
| +2,571% | +$108K | ﹤0.01% | 717 |
|
2019
Q2 | $10K | Buy |
+1,451
| New | +$10K | ﹤0.01% | 1024 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 1217 |
|
2018
Q4 | – | Sell |
-34,090
| Closed | -$756K | – | 1366 |
|
2018
Q3 | $756K | Sell |
34,090
-17,600
| -34% | -$390K | 0.01% | 351 |
|
2018
Q2 | $848K | Buy |
+51,690
| New | +$848K | 0.01% | 327 |
|